ARCHIVES

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

May 8, 1992

GAO Recommends Tighter Policies on NIH Recusals.

June 29, 2007

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984